QCRG is a collaborative group of over 300 researchers from UCSF and around the world that has focused on finding solutions for COVID-19.
Scientists at the UC San Francisco (UCSF) Quantitative Biosciences Institute (QBI) and the QBI Coronavirus Research Group (QCRG) have been initially awarded $67.5 million from the National Institute of Allergy and Infectious Diseases (NIAID) to support its mission of pandemic preparedness. The award covers a three-year period and establishes one of the country’s first Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern, which are multidisciplinary academic-industry research centers to develop candidate antivirals for COVID-19 and other viruses with pandemic potential.
The SARS-CoV-2 pandemic highlighted the need for speedy discovery and fast development of therapeutic strategies. Faced with a problem that required collaboration across disciplines and an unprecedented speed of discovery, QBI UCSF was able to form QCRG in a matter of days.
Sign up to stay tuned to upcoming news and events.